Abstract:Objective To study the preoperative serum expressions of microRNA-27a (miR-27a) and microRNA-203a-3p (miR-203a-3p) in patients with esophageal cancer and their relationship with clinical outcomes of patients.Methods From March 2016 to March 2017, 123 patients with esophageal cancer who underwent radical resection for esophageal cancer in our hospital were selected as the study group. Another 64 healthy people who underwent health checkup during the same period were selected as the control group. The serum levels of miR-27a and miR-203a-3p before the operation in the study group and those during the health checkup in the control group were detected by quantitative real-time polymerase chain reaction (qRT-PCR). The relationship between serum levels of miR-27a and miR-203a-3p and clinicopathological characteristics in patients with esophageal cancer was analyzed. Kaplan-Meier survival curves were used to analyze the relationship between serum levels of miR-27a and miR-203a-3p and the prognosis of patients. Univariate and multivariate COX regression analysis was performed to determine factors influencing prognosis of patients with esophageal cancer.Results The serum levels of miR-27a and miR-203a-3p in the study group were higher than those in the control group (P < 0.05). Besides, the serum levels of miR-27a and miR-203a-3p before the radical surgery in esophageal cancer patients with stage Ⅲ tumors, poorly differentiated tumors and lymph node metastasis were higher than those in esophageal cancer patients with stage Ⅰ to Ⅱ tumors, well differentiated tumors and no lymph node metastasis (P < 0.05). There was no difference in the serum levels of miR-27a and miR-203a-3p before the radical surgery in esophageal cancer patients with different age, sex and tumor location (P >0.05). The 5-year overall survival rate in the miR-27a high expression group was lower than that in the miR-27a low expression group (P < 0.05). The 5-year overall survival rate of patients with high miR-203a-3p expression was lower than that of patients with low miR-203a-3p expression group (P < 0.05). Univariate COX regression analysis showed that tumor stage [H^R = 1.730 (95% CI: 1.434, 2.099) ], lymph node metastasis [H^R= 1.602 (95% CI: 1.191, 2.153) ], miR-27a [H^R = 2.041 (95% CI: 1.813, 2.463) ] and miR-203a-3p [H^R = 2.060 (95% CI: 1.921, 2.279) ] were prognostic factors of patients with esophageal cancer (P < 0.05). Multivariate COX regression analysis showed that stage III tumor [H^R= 1.973 (95% CI: 1.245, 3.219) ], lymph node metastasis [H^R= 2.637 (95% CI: 1.158, 6.008)], the level of miR-27a≥ 3.09 [H^R= 2.484 (95% CI: 1.435, 4.301) ], and the level of miR-203a-3p ≥ 2.79 [H^R = 1.660 (95% CI: 1.236, 3.058) ] were independent risk factors affecting the prognosis of patients with esophageal cancer (P < 0.05).Conclusions The serum expressions of miR-27a and miR-203a-3p are up-regulated in patients with esophageal cancer, and their expressions are related to tumor TNM stage, degree of differentiation and lymph node metastasis. Besides, high expressions of miR-27a and miR-203a-3p are independent risk factors for poor prognosis of patients undergoing radical resection for esophageal cancer.